Fonction surrénalienne après bolus d'étomidate en chirurgie cardiaque : une étude rétrospective

Rapport de synthèse : Enjeux et contexte Etant le seul agent hypnotique à avoir des effets hémodynamiques négligeables, l'étomidate est souvent considéré comme l'agent anesthésique d'induction de choix lors de l'anesthésie de patients hémodynamiquement instables Cependant, une dose unique de cet hypnotique imidazolé inhibe la 11-ß hydroxylase, une enzyme mitochondriale de la phase terminale de la synthèse du cortisol. Au Centre Hospitalier Universitaire Vaudois, tout patient candidat à une chirurgie cardiaque reçoit de l'étomidate à l'induction de l'anesthésie. L'objectif de cette étude a été de déterminer l'incidence de dysfonction surrénalienne chez les patients subissant une chirurgie cardiaque et présentant un état de choc postopératoire nécessitant de hautes doses de noradrénaline. t Méthodes Une étude rétrospective et descriptive a été réalisée dans le service de médecine intensive adulte du Centre Hospitalier Universitaire Vaudois. Soixante-trois patients admis en réanimation après chirurgie cardiaque nécessitant plus de 0.2 νg/kg/min de noradrénaline au cours des premières 48 heures postopératoires ont été étudiés. L'insuffisance surrénalienne absolue a été définie par un cortisol basal inférieur à 414mmo/L, l'insuffisance surrénalienne relative par un cortisol basal entre 414mmo/L et 938nmo/L avec augmentation de la cortisolémie (à 60 minute .après un test de stimulation par 250Ng of corticotropine de synthèse) inférieure à 250mmo/L. Statistiques Les résultats ont été rapportés en médianes et extrêmes. Les comparaisons entre les groupes ont été réalisées, lorsque cela était indiqué, par un test Chi 2 ou un test de Wilcoxon. Pour les comparaisons répétées des taux de cortisol et des doses de noradrénaline, une correction de Bonferroni a été appliquée. Une valeur de p<0,05 a été considérée comme significative. Résultats : Quatorze patients [22%] ont présenté une fonction surrénalienne normale, 10 [16%] une insuffisance surrénalienne absolue et 39 [62%] une insuffisance surrénalienne relative. Tous les patients ont reçu une substitution stéroïdienne, sans aucune différence d'évolution clinique entre les différents groupes. Conclusions : L'incidence d'insuffisance surrénalienne chez les patients qui ont reçu un bolus d'étomidate à l'induction, subi une chirurgie cardiaque avec circulation extra-corporelle et présenté une défaillance circulatoire postopératoire est élevée. Il convient probablement de garder à l'esprit qu'une telle insuffisance peut contribuer à l'état de choc du patient. Dans de telles circonstances, l'exploration de la fonction surrénalienne et la suppléance par stéroïdes d'une éventuelle insuffisance surrénalienne en attendant les résultats des examens endocrinologiques devraient être discutés.

Temozolomide: a milestone in neuro-oncology and beyond?

Temozolomide (Temodal, Temodar), an imidazol derivative, is a second-generation alkylating agent. The orally available prodrug with the capacity of crossing the blood-brain barrier received accelerated US FDA approval in 1999. Three pivotal Phase II trials showed modest activity in the treatment of recurrent anaplastic astrocytoma glioblastoma. In 2005, the FDA and the European Agency for the Evaluation of Medicinal Products approved temozolomide for use in newly diagnosed glioblastoma, in conjunction with radiotherapy, based on an European Organisation for Research and Treatment of Cancer/National Cancer Institute of Canada Phase III trial. The adverse events associated with temozolomide are mild-to-moderate and generally predictable; the most serious are noncumulative and reversible myelosuppression and, in particular, thrombocytopenia, which occurs in less than 5% of patients. Continuous temozolomide administration is associated with profound CD4-selective lymphocytopenia. Molecular studies have suggested that the benefit of temozolomide chemotherapy is restricted to patients whose tumors have a methylated methylguanine methyltransferase gene promotor and are thus unable to repair some of the chemotherapy-induced DNA damage. Temozolomide is under investigation for other disease entities, in particular lower-grade glioma, brain metastases and melanoma.

Efeitos ópticos - eletrônicos de solventes nas polarizabilidades eletrônicas do íon Ni2+ no complexo [Ni(C3H4N2)6](CF3SO3)2

Polarizabilidades eletrônicas foram determinadas para o sal de tifluorometanosulfonato de níquel e para o complexo com imidazol, em soluções de metanol e de acetonitrila. A partir dos espectros eletrônicos, registrados numa concentração de 10-3 mol L-1 e pelo uso de um programa SIMP2FOS para o cálculo da força do oscilador experimental e POLAZ-F para o cálculo das polarizabilidades eletrônicas, foi possível perceber a distinta influência dos solventes na deformação da nuvem eletrônica do níquel (II).

Avaliação de herbicidas no controle de plantas daninhas na cultura da soja

Foi conduzido em Serranópolis, GO, um ensaio objetivando avaliar a eficiência e a seletividade de herbicidas no controle de plantas daninhas na cultura da soja (Glycine max (L.) Merril), utilizando-se os seguintes tratamentos: A) 100 g/ha de imazethapyr (ácido 2-[4,5-dihidro-4-metil-4(1-metiletil)-5-oxo-1H-imidazol-2-ilo]-5-etil-3-piridinacarboxilico) + surfactante, a 0,25% v/v; B) tratamento A e 15 dias após, 230 g/ha de sethoxydim (2-1-etoximino-butil-5-2(etiltio)-propil-3-hidroxi-2-ciclohexeno-1-ona) + óleo mineral, a 0,25% v/v; C) 230 g/ha de sethoxydim + óleo mineral, a 0,25% v/v; D) 480 + 200 + 230 g/ha de bentazon (3-isopropil-2,1,3-benzotiadiazinona-(4)-2,2-dióxido) + fomesafen (5-)2-cloro-4-(trifluorometil-fenoxi)N-metilsulfonil-2-nitrobenzamida) + sethoxydim + óleo mineral, 0,25% v/v; E) 150 g/ha de imazaquim (2-[4,5-dihidro-4-metil-4-(1-metiletil)-5-oxo-1H-imidazol-2-ilo]-3-quinolinacarboxílico) pré-e e 230 g/ha de sethoxydim + óleo mineral, 0,25% v/v; F) 250 g/ha de fomesafen + 187 g/ha de fluazipop-p-butil (butil-(R)-2-(4-(5-trifluorometil-2-piridiloxi)-fenoxi)-propionato) + surfactante a 0,2% v/v; G) 120 g/ha de imazethapyr + surfactante a 0,2% v/v; H) testemunha capinada; I) testemunha não capinada. O delineamento experimental foi de blocos ao acaso, com quatro repetições. O capim-custódio (Pennisetum setosum (Swartz) L. Rich) foi eficientemente controlado por todos os tratamentos químicos, enquanto a falsa-serralha (Emilia sonchifolia DC.) foi somente pelo tratamento D. O capim-carrapicho (Cenchrus echinatus L.) por C, D, E e F. O joá-de-capote (Nicandra physaloides (L.) Pers.) por D.F. e G. Ocorreram injúrias iniciais às plantas de soja, nos tratamentos D, E. e F. As alturas de plantas e de inserção da primeira vagem, além do rendimento de grãos, não foram influenciados significativamente pelos herbicidas.

Influência da cobertura morta no comportamento dos herbicidas imazaquin e clomazone

Experimentos de campo e bioensaios em casa-de-vegetação foram realizados para se estudar a influência da cobertura morta de trigo (Triticum aestivum L.) no comportamento dos herbicidas imazaquin {ácido 2-[4,5 dihidro-4-metil-4-(1-metiletil)-5-oxo-1H-imidazol-2-ilo]-3-quinolinacarboxílico} e clomazone {2-[(2-clorofenil)metil]-4,4-dimetil-3-isoxazolidinona}, aplicados em pré-emergência na cultura da soja [Glycine max (L.) Merril], no sistema de plantio direto. O clomazone mostrou evidências de ter sido interceptado pela cobertura morta. A presença da cobertura morta não influiu na retenção do imazaquin, sendo este lixiviado da palha para o solo com as chuvas que ocorreram após a aplicação.

Synthesis and utilization of guanidine catalysts for applications directed towards the preparation of butenolide and modified amino acid derivatives

Development of guanidine catalysts is explored through direct iminium chloride and amine coupling, alongside a 2-chloro-l,3-dimethyl-IH-imidazol-:-3-ium chloride (DMC) induced thiourea cyclization. Synthesized achiral catalyst N-(5Hdibenzo[ d,t][1,3]diazepin-6(7H)-ylidene)-3,5-bis(trifluoromethyl) aniline proved unsuccessful towards O-acyl migrations, however successfully catalyzed the vinylogous aldol reaction between dicbloro furanone and benzaldehyde. Incorporating chirality into the guanidine catalyst utilizing a (R)-phenylalaninol auxiliary, generating (R)-2-((5Hdibenzo[ d,t] [1,3 ]diazepin-6(7H)-ylidene ) amino )-3 -phenylpropan-l-ol, demonstrated enantioselectivity for a variety of adducts. Highest enantiomeric excess (ee) was afforded between dibromofuranone and p-chlorobenzaldehyde, affording the syn conformation in 96% ee and the anti in 54% ee, with an overall yield of30%. Attempts to increase asymmetric induction were focused on incorporation of axial chirality to the (R)phenylalaninol catalyst using binaphthyl diamine. Incorporation of (S)-binaphthyl exhibited destructive selectivity, whereas incorporation of (R)-binaphthyl demonstrated no effects on enantioselectivity. Current studies are being directed towards identifying the catalytic properties of asymmetric induction with further studies are being aimed towards increasing enantioselectivity by increasing backbone steric bulk.

Decarboxylative Generation of Carbenes for the Synthesis of N-Heterocyclic Carbene Copper(I) Complexes - Applications in the Oxidative Coupling of 2-Naphthols

Le présent mémoire décrit la synthèse et l’utilité de complexes Cu-NHC. En premier lieu, la synthèse de complexes de cuivre porteurs de ligand(s) de type carbène-N-hétérocyclique (NHC) via une génération décarboxylative de carbènes sera présentée. En effet, de précédents rapports font état de l’utilisation de carboxylates d’imidazol(in)ium en tant que précurseurs carbéniques sous conditions thermolytiques. Ainsi, la présente étude montre l’utilisation de ces espèces zwitterioniques pour la synthèse de complexes de cuivre(I) mono- et bis-NHC comportant divers substituants et contre-ions. Une seconde partie du projet se concentrera sur l’évaluation de complexes Cu-NHC en tant que catalyseurs pour la synthèse de 2,2’-binaphtols via une réaction de couplage oxydatif de naphtols. L’objectif de ce projet de recherche est d’étudier les effets de variations structurales de différents complexes Cu-NHC afin de construire un processus catalytique plus efficace. Les effets de la structure du catalyseur sur la réaction de couplage ont été évalués en variant son contre-ion, le nombre de ligands NHC se coordonnant au cuivre, ainsi que la nature des substituants du ligand.

Zinc(II) mediated synthesis of an N-substituted 2-(2-pyridyl)imidazole from a 1,2-diketone and 2-(aminomethyl)pyridine and its ligational behaviour

Reaction of anhydrous ZnCl2 with the 1:2 condensate (L) of benzil and 2-(aminomethyl)pyridine in methanol gives monomeric ZnL'Cl-2 (1) where L' is 2-[(4,5-diphenyl-2-pyridin-2-yl-1H-imidazol-1-yl)-methyl]pyridine. In the X-ray crystal structure, 1 is found to contain tetrahedral zinc with an N2Cl2 coordination sphere and the N-substituent methylpyridine fragment hanging as a free arm. A tentative mechanism is proposed for the zinc mediated conversion of L-->L'. Demetallation of 1 by the action of aqueous NaOH yields L' in the free state. When L' is reacted with Zn(ClO4)(2).6H(2)O in a 1:2 molar proportion, [Zn(L')(2)](n)(ClO4)(2n).(H2O)(n/2).(CH2Cl2)(n/2) (2) is obtained. The zinc atom in 2, as revealed by X-ray crystallography, has a trigonal bipyramidal N-5 coordination sphere. There are two independent ligands in the asymmetric unit of 2. One of them bonds only to one zinc atom in a bidentate mode with the N-substituent methylpyridine hanging free while the other ligand binds to two different zinc atoms in a tridentate fashion, employing the N-substituent methylpyridine nitrogen atom to form the polymeric one-dimensional chain cation.

Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy

The ruthenium complex,trans-[Ru(Bz)(NH3)(4)SO2](CF3SO3)(2) 1, Bz = benznidazole (N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide), is more hydrosoluble and more active (IC50try/1 h = 79 +/- 3 mu M) than free benznidazole 2 (IC50try/1 h > 1 mM). 1 also exhibits low acute toxicity in vitro (IC50macrophages > 1 mM) and in vivo (400 mu mol/kg < LD50 < 600 mu mol/kg) and the formation of hydroxylamine is more favorable in 1 than in 2 by 9.6 kcal/mol. In murine acute models of Chagas` disease, 1 was more active than 2 even when only one dose was administrated. Moreover, 1 at a thousand-fold smaller concentration than the considered optimal dose for 2 (385 mu mol/kg/day = 100 mg/kg/day), proved to be sufficient to protect all infected mice, eliminating the amastigotes in their hearts and skeletal muscles as observed in H&E micrographics.

Metronidazole release using natural rubber latex as matrix

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

alpha(1)-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Cytochemical localization of lipids in the venom glands of worker bees of Apis mellifera (Hymenoptera, Apidae)

The technique of osmium imidazol for the ultrastructural detection of lipids in the secretory cells of the venom gland of 14-days old worker bees of Apis mellifera L. demonstrated the presence of these components at various sites of the gland. These lipids were found mainly associated to the external region of the basal lamina and the microvilli, in the intercellular spaces, in the cuticle of the collecting canaliculi and in the secretion contained in the glandular lumen. Therefore, in addition to revealing the presence of lipids in the secretion, this technique also allowed us to attribute an exogenous origin to the lipids in the secretion; they are taken up from the haemolymph.

Polybioside, a Neuroactive Compound from the Venom of the Social Wasp Polybia paulista

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Differential distribution of functional alpha(1)-adrenergic receptor subtypes along the rat tail artery

The rat tail artery has been used for the study of vasoconstriction mediated by alpha(1A)-adrenoceptors (ARs). However, rings from proximal segments of the tail artery (within the initial 4 cm, PRTA) were at least 3- fold more sensitive to methoxamine and phenylephrine (n = 6 - 12; p < 0.05) than rings from distal parts (between the sixth and 10th cm, DRTA). Interestingly, the imidazolines N-[ 5-( 4,5- dihydro- 1H- imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen- 1- yl] methanesulfonamide hydrobromide (A-61603) and oxymetazoline, which activate selectively alpha(1A)- ARs, were equipotent in PRTA and DRTA (n = 4 - 12), whereas buspirone, which activates selectively alpha(1D)-AR, was approximate to 70-fold more potent in PRTA than in DRTA (n = 8; p < 0.05). The selective alpha(1D)-AR antagonist 8-[2-[4-(methoxyphenyl)-1-piperazinyl] ethyl]-8-azaspiro[4.5] decane-7,9-dione dihydrochloride (BMY- 7378) was approximate to 70- fold more potent against the contractions induced by phenylephrine in PRTA (pK(B) of approximate to 8.45; n = 6) than in DRTA (pK B of approximate to 6.58; n = 6), although the antagonism was complex in PRTA. 5-Methylurapidil, a selective alpha(1A)-antagonist, was equipotent in PRTA and DRTA (pK(B) of approximate to 8.4), but the Schild slope in DRTA was 0.73 +/- 0.05 ( n = 5). The noncompetitive alpha(1B)-antagonist conotoxin rho-TIA reduced the maximal contraction induced by phenylephrine in DRTA, but not in PRTA. These results indicate a predominant role for alpha(1A)-ARs in the contractions of both PRTA and DRTA but with significant coparticipations of alpha(1D)-ARs in PRTA and alpha(1B)-ARs in DRTA. Semiquantitative reverse transcription-polymerase chain reaction revealed that mRNA encoding alpha(1A)- and alpha(1B)-ARs are similarly distributed in PRTA and DRTA, whereas mRNA for alpha(1D)-ARs is twice more abundant in PRTA. Therefore, alpha(1)-ARs subtypes are differentially distributed along the tail artery. It is important to consider the segment from which the tissue preparation is taken to avoid misinterpretations on receptor mechanisms and drug selectivities. antagonism was complex in PRTA. 5- Methylurapidil, a selective alpha(1A)-antagonist, was equipotent in PRTA and DRTA (pK(B) of approximate to 8.4), but the Schild slope in DRTA was 0.73 +/- 0.05 ( n = 5). The noncompetitive alpha(1B)-antagonist conotoxin rho-TIA reduced the maximal contraction induced by phenylephrine in DRTA, but not in PRTA. These results indicate a predominant role for alpha(1A)-ARs in the contractions of both PRTA and DRTA but with significant coparticipations of alpha(1D)-ARs in PRTA and alpha(1B)-ARs in DRTA. Semiquantitative reverse transcription-polymerase chain reaction revealed that mRNA encoding alpha(1A)- and alpha(1B)- ARs are similarly distributed in PRTA and DRTA, whereas mRNA for alpha(1D)-ARs is twice more abundant in PRTA. Therefore, alpha(1)-ARs subtypes are differentially distributed along the tail artery. It is important to consider the segment from which the tissue preparation is taken to avoid misinterpretations on receptor mechanisms and drug selectivities.

Voltammetric Study of a Cubic Silsesquioxane Organically Modified with Imidazole and their Subsequent Reaction with Cadmium and Hexacyanoferrate (III)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)